ritonavir &#160; Turanci (Q422618)

https://www.whocc.no/atc_ddd_index/?code=J05AE03

active ingredient in ^Turanci

Norvir ^Turanci

1 reference

stated in ^Turanci

RxNorm ^Turanci

RxNorm ID ^Turanci

196479

retrieved ^Turanci

14 Faburairu 2018

nirmatrelvir/ritonavir ^Turanci

0 references

World Health Organisation international non-proprietary name ^Turanci

ritonavir (Turanci)

1 reference

stated in ^Turanci

ChEBI ^Turanci

ChEBI ID ^Turanci

ritonavir (Turanci)

retrieved ^Turanci

19 Oktoba 2016

medical condition treated ^Turanci

Kanjamau

2 references

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

stated in ^Turanci

Drug Indications Extracted from FAERS ^Turanci

retrieved ^Turanci

2 Oktoba 2018

human immunodeficiency virus infectious disease ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ^Turanci

retrieved ^Turanci

13 Disamba 2016

Hepatitis C

1 reference

stated in ^Turanci

Drug Indications Extracted from FAERS ^Turanci

retrieved ^Turanci

2 Oktoba 2018

Koronavirus 2019

1 reference

stated in ^Turanci

significant drug interaction ^Turanci

bosentan ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

carbamazepin ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

rifabutin ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

rifampicin ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

rifapentine ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

domperidone ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ergotamine ^Turanci

ergotism ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

posaconazole ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

simvastatin ^Turanci

rhabdomyolysis ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

simvastatin ^Turanci

muscular disease ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

rosuvastatin ^Turanci

rhabdomyolysis ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

rosuvastatin ^Turanci

muscular disease ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

atorvastatin ^Turanci

rhabdomyolysis ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

atorvastatin ^Turanci

muscular disease ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-methadone ^Turanci

withdrawal symptom ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-methadone ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

buprenorphine ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

buprenorphine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

alfentanil ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fluticasone ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fluticasone ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

dexamethasone ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

dexamethasone ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

Prednisolone

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

Prednisolone

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

prednisone ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

prednisone ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

triamcinolone ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

triamcinolone ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

budesonide ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

budesonide ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

verapamil ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

diltiazem ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

docetaxel trihydrate ^Turanci

thrombocytopenia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

docetaxel trihydrate ^Turanci

leukopenia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

docetaxel trihydrate ^Turanci

zazzaɓi

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

docetaxel trihydrate ^Turanci

gudawa

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

docetaxel trihydrate ^Turanci

Rashin jini

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

nifedipine ^Turanci

sinus bradycardia ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

nifedipine ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

nifedipine ^Turanci

acute kidney injury ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sirolimus ^Turanci

leukopenia ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sirolimus ^Turanci

Rashin jini

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sirolimus ^Turanci

thrombocytopenia ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sirolimus ^Turanci

Achor-Smith syndrom ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sirolimus ^Turanci

gudawa

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

disopyramide ^Turanci

heart arrhythmia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

disopyramide ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

disopyramide ^Turanci

Gazawar zuciya

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ranolazine ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ranolazine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ranolazine ^Turanci

pulseless electrical activity ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ranolazine ^Turanci

cardiotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

dasatinib monohydrate ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

panobinostat ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sufentanil ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

crizotinib ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

eliglustat ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ivabradine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

dabrafenib ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

quetiapine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

clarithromycin ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

vinblastine ^Turanci

neutropenia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

vinblastine ^Turanci

Functional constipation ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

vinblastine ^Turanci

peripheral neuropathy ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pazopanib ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

midazolam ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

midazolam ^Turanci

sedation complication ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pimozide ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pimozide ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pimozide ^Turanci

pulseless electrical activity ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pimozide ^Turanci

cardiotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

tacrolimus ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

Ketoconazole ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ta jiki ma'amala da

cytochrome P450 family 3 subfamily A member 4 ^Turanci

subject has role ^Turanci

enzyme inhibitor ^Turanci

1 reference

stated in ^Turanci

IUPHAR/BPS Guide to PHARMACOLOGY ^Turanci

Guide to Pharmacology Ligand ID ^Turanci

8804

retrieved ^Turanci

17 Agusta 2016

cytochrome P450 family 3 subfamily A member 5 ^Turanci

subject has role ^Turanci

enzyme inhibitor ^Turanci

1 reference

stated in ^Turanci

IUPHAR/BPS Guide to PHARMACOLOGY ^Turanci

Guide to Pharmacology Ligand ID ^Turanci

8804

retrieved ^Turanci

17 Agusta 2016

route of administration ^Turanci

oral administration ^Turanci

0 references

legal status (medicine) ^Turanci

boxed warning ^Turanci

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (Turanci)

pregnancy category ^Turanci

Australian pregnancy category B3 ^Turanci

1 reference

an ɗauko daga

English Wikipedia ^Turanci

US pregnancy category B ^Turanci

1 reference

an ɗauko daga

English Wikipedia ^Turanci

LiverTox likelihood score ^Turanci

LiverTox toxicity likelihood category C ^Turanci

1 reference

stated in ^Turanci

LiverTox ^Turanci

retrieved ^Turanci

8 Afirilu 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Ritonavir

last update ^Turanci

1 Satumba 2017

subject has role ^Turanci

xenobiotic-transporting ATPase inhibitor ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

5 Maris 2018

HIV protease inhibitors ^Turanci

2 references

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1

retrieved ^Turanci

5 Maris 2018

stated in ^Turanci

Medical Subject Headings ^Turanci

MeSH descriptor ID ^Turanci

D019438

retrieved ^Turanci

15 Maris 2018

cytochrome P-450 CYP3A inhibitors ^Turanci

1 reference

stated in ^Turanci

Medical Subject Headings ^Turanci

MeSH descriptor ID ^Turanci

D019438

retrieved ^Turanci

15 Maris 2018

essential medicine ^Turanci

0 references

antiviral drug ^Turanci

1 reference

stated in ^Turanci

ChEBI ^Turanci

bactericide ^Turanci

2 references

ChEBI ID ^Turanci

45409

stated in ^Turanci

ChEBI ^Turanci

Commons category ^Turanci

Ritonavir

0 references

catalog ^Turanci

CAS COVID-19 Anti-Viral Candidate Compounds ^Turanci

0 references

Identifiers

InChI ^Turanci

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

ritonavir (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

InChIKey ^Turanci

2 references

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

ritonavir (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

stated in ^Turanci

ChEBI release 2020-09-01 ^Turanci

CAS Registry Number ^Turanci

155213-67-5

2 references

stated in ^Turanci

Global Substance Registration System ^Turanci

UNII ^Turanci

ritonavir (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

InChIKey ^Turanci

stated in ^Turanci

CAS Common Chemistry ^Turanci

retrieved ^Turanci

10 Afirilu 2021

https://commonchemistry.cas.org/detail?cas_rn=155213-67-5

ChemSpider ID ^Turanci

347980

1 reference

stated in ^Turanci

ChemSpider ^Turanci

ChemSpider ID ^Turanci

Ritonavir (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

PubChem CID ^Turanci

392622

2 references

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

ritonavir (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

InChIKey

InChIKey ^Turanci

Reaxys registry number ^Turanci

768009

1 reference

stated in ^Turanci

ChEBI ^Turanci

ChEBI ID ^Turanci

ritonavir (Turanci)

retrieved ^Turanci

19 Oktoba 2016

ChEBI ID ^Turanci

45409

mapping relation type ^Turanci

exact match ^Turanci

2 references

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

RITONAVIR (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1

International Chemical Identifier ^Turanci

InChI ^Turanci

ChEMBL ID ^Turanci

CHEMBL163

1 reference

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

RITONAVIR (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

SureChEMBL ID ^Turanci

SCHEMBL6679

2 references

based on heuristic ^Turanci

inferred from InChIKey ^Turanci

InChIKey

InChIKey ^Turanci

MSBNK-Athens_Univ-AU219201

UniChem compound ID ^Turanci

74629

1 reference

stated in ^Turanci

UniChem ^Turanci

CCDC Number ^Turanci

710529

1 reference

stated in ^Turanci

Cambridge Structural Database ^Turanci

retrieved ^Turanci

10 Janairu 2023

based on heuristic ^Turanci

InChIKey match ^Turanci

CSD Refcode ^Turanci

YIGPIO03

1 reference

stated in ^Turanci

Cambridge Structural Database ^Turanci

retrieved ^Turanci

10 Janairu 2023

based on heuristic ^Turanci

InChIKey match ^Turanci

MassBank accession ID ^Turanci

0 references

MSBNK-Athens_Univ-AU219202

0 references

MSBNK-Athens_Univ-AU219203

0 references

MSBNK-Athens_Univ-AU219204

0 references

MSBNK-Athens_Univ-AU219205

0 references

MSBNK-Athens_Univ-AU219207

0 references

MSBNK-Athens_Univ-AU219208

0 references

MSBNK-Athens_Univ-AU219209

0 references

MSBNK-Athens_Univ-AU219210

0 references

MSBNK-Athens_Univ-AU219211

0 references

MSBNK-Athens_Univ-AU219230

0 references

MSBNK-Athens_Univ-AU219231

0 references

MSBNK-Athens_Univ-AU219232

0 references

MSBNK-Athens_Univ-AU219233

0 references

MSBNK-Athens_Univ-AU219234

0 references

MSBNK-Waters-WA001498

0 references

MSBNK-Waters-WA001499

0 references

MSBNK-Waters-WA001500

0 references

MSBNK-Waters-WA001501

0 references

MSBNK-Waters-WA001502

0 references

MSBNK-Waters-WA001503

0 references

SPLASH ^Turanci

splash10-0002-1890100200-749c81b805f598dabd2c

0 references

splash10-000t-4971130000-6788130f61c4c61a395b

0 references

splash10-01dj-0490400400-51a0b80eb0fdf1a6ade4

0 references

HSDB ID ^Turanci

7160

1 reference

stated in ^Turanci

Hazardous Substances Data Bank ^Turanci

HSDB ID ^Turanci

7160

ranar wallafa

28 Oktoba 2019

RITONAVIR (Turanci)

retrieved ^Turanci

10 Mayu 2021

DSSTox substance ID ^Turanci

DTXSID1048627

2 references

stated in ^Turanci

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard ^Turanci

InChIKey

InChIKey ^Turanci

DSSTOX compound identifier ^Turanci

DTXCID8028553

0 references

LiverTox ID ^Turanci

Ritonavir

0 references

NSC number ^Turanci

693184

0 references

760369

0 references

EC number ^Turanci

605-001-5

1 reference

stated in ^Turanci

ECHA Substance Infocard database ^Turanci

ECHA Substance Infocard ID ^Turanci

100.125.710

retrieved ^Turanci

27 Disamba 2018

1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[(2S)-3-methyl-2-{[methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}butanamido]-1,6-diphenylhexan-2-yl]carbamate (Turanci)

quotation ^Turanci

CAS no.: 155213-67-5 (Turanci)

ECHA Substance Infocard ID ^Turanci

100.125.710

1 reference

stated in ^Turanci

ECHA Substance Infocard database ^Turanci

ECHA Substance Infocard ID ^Turanci

100.125.710

retrieved ^Turanci

27 Disamba 2018